Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 530

1.

The WATCHMAN left atrial appendage closure device for atrial fibrillation.

Möbius-Winkler S, Sandri M, Mangner N, Lurz P, Dähnert I, Schuler G.

J Vis Exp. 2012 Feb 28;(60). pii: 3671. doi: 10.3791/3671.

2.

Catheter ablation in combination with left atrial appendage closure for atrial fibrillation.

Swaans MJ, Alipour A, Rensing BJ, Post MC, Boersma LV.

J Vis Exp. 2013 Feb 26;(72):e3818. doi: 10.3791/3818.

4.

Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial.

Reddy VY, Doshi SK, Sievert H, Buchbinder M, Neuzil P, Huber K, Halperin JL, Holmes D; PROTECT AF Investigators.

Circulation. 2013 Feb 12;127(6):720-9. doi: 10.1161/CIRCULATIONAHA.112.114389. Epub 2013 Jan 16.

5.

Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY.

J Am Coll Cardiol. 2014 Jul 8;64(1):1-12. doi: 10.1016/j.jacc.2014.04.029. Erratum in: J Am Coll Cardiol. 2014 Sep 16;64(11):1186.

6.

Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).

Reddy VY, Möbius-Winkler S, Miller MA, Neuzil P, Schuler G, Wiebe J, Sick P, Sievert H.

J Am Coll Cardiol. 2013 Jun 25;61(25):2551-6. doi: 10.1016/j.jacc.2013.03.035. Epub 2013 Apr 10.

7.

Clinical Results of Left Atrial Appendage Closure with Watchman Device in Patients with Atrial Fibrillation.

Pheerawong P, Songmuang SB, Lertsuwunseri V, Satitthummanid S, Srimahachota S.

J Med Assoc Thai. 2015 Oct;98(10):942-9.

PMID:
26638585
8.

The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.

Ramlawi B, Abu Saleh WK, Edgerton J.

Methodist Debakey Cardiovasc J. 2015 Apr-Jun;11(2):100-3. doi: 10.14797/mdcj-11-2-100. Review.

9.

Overview of the Food and Drug Administration circulatory system devices panel meetings on WATCHMAN left atrial appendage closure therapy.

Waksman R, Pendyala LK.

Am J Cardiol. 2015 Feb 1;115(3):378-84. doi: 10.1016/j.amjcard.2014.11.011. Epub 2014 Nov 12. Review.

PMID:
25579887
10.

Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience.

Chun KR, Bordignon S, Urban V, Perrotta L, Dugo D, Fürnkranz A, Nowak B, Schmidt B.

Heart Rhythm. 2013 Dec;10(12):1792-9. doi: 10.1016/j.hrthm.2013.08.025. Epub 2013 Aug 22.

PMID:
23973952
11.

Left atrial appendage closure: a new technique for clinical practice.

John Camm A, Colombo A, Corbucci G, Padeletti L.

Heart Rhythm. 2014 Mar;11(3):514-21. doi: 10.1016/j.hrthm.2013.11.030. Epub 2013 Nov 28. Review.

12.

Intraprocedural and long-term incomplete occlusion of the left atrial appendage following placement of the WATCHMAN device: a single center experience.

Bai R, Horton RP, DI Biase L, Mohanty P, Pump A, Cardinal D, Scallon C, Mohanty S, Santangeli P, Brantes MC, Sanchez J, Burkhardt JD, Zagrodzky JD, Gallinghouse GJ, Natale A.

J Cardiovasc Electrophysiol. 2012 May;23(5):455-61. doi: 10.1111/j.1540-8167.2011.02216.x. Epub 2011 Nov 14.

PMID:
22082312
13.

Percutaneous closure of the left atrial appendage using the Amplatzer Cardiac Plug in patients with atrial fibrillation: evaluation of safety and feasibility.

Streb W, Szymała M, Kukulski T, Nowak J, Lekston A, Sokal A, Knapik P, Czapla J, Zbieralska E, Kalarus Z.

Kardiol Pol. 2013;71(1):8-16.

14.

Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation.

Landmesser U, Holmes DR Jr.

Eur Heart J. 2012 Mar;33(6):698-704. doi: 10.1093/eurheartj/ehr393. Epub 2011 Oct 31. Review.

15.
16.

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.

Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P; PROTECT AF Investigators.

Lancet. 2009 Aug 15;374(9689):534-42. doi: 10.1016/S0140-6736(09)61343-X. Erratum in: Lancet. 2009 Nov 7;374(9701):1596.

PMID:
19683639
17.

Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study.

Block PC, Burstein S, Casale PN, Kramer PH, Teirstein P, Williams DO, Reisman M.

JACC Cardiovasc Interv. 2009 Jul;2(7):594-600. doi: 10.1016/j.jcin.2009.05.005.

18.

Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillation.

Alli O, Doshi S, Kar S, Reddy V, Sievert H, Mullin C, Swarup V, Whisenant B, Holmes D Jr.

J Am Coll Cardiol. 2013 Apr 30;61(17):1790-8. doi: 10.1016/j.jacc.2013.01.061. Epub 2013 Feb 28.

19.
20.

Transcatheter closure of the left atrial appendage: initial experience with the WATCHMAN device.

Ding J, Zhu J, Lu J, Ding X, Zhang X, Lu W, Ao M, Ma G.

Int J Clin Exp Med. 2015 Sep 15;8(9):15230-7. eCollection 2015.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk